Conversely, the authors of the study observed that treatment of tumor cells with the antibacterial compound nitroxoline by counteracting TRIM25-mediated PTEN ubiquitination was able to restore cell death sensitivity of NSCLC to cisplatin [75]. The gene discussed is TRIM25; the disease is non-small cell lung carcinoma.